INTRODUCTION
Cytochrome P-450-dependent mixed-function monooxygenases (P-450s) are a supergene family of enzymes that catalyse the oxidation of an extremely wide range of lipophilic chemicals by the addition of one atom of molecular oxygen into the substrate. They are widespread in nature and play a central role in the metabolism of endogenous compounds, such as steroids and fatty acids, and also a variety of foreign compounds [for reviews see Ortiz de Montellano (1986) , Gonzalez (1989 Gonzalez ( , 1990 and Nebert et al. (1991) ]. In general, P-450s require a separate reductase system in order to function catalytically. For example, the microsomal P-450s require the flavoprotein P-450 reductase as an electron donor, whereas mitochondrial and most bacterial P-450s require an iron-sulphur-containing redoxin and an FAD-containing redoxin reductase. A so-far unique exception to this generalization is the 118 kDa fatty acid mono-oxygenating P-450 BM-3 from Bacillus megaterium ATCC 14581 (Narhi & Fulco, 1986) .
P450 BM-3 is a bifunctional polypeptide comprising a 54 kDa N-terminal 'P-450' domain linked to a 64 kDa C-terminal 'reductase' domain and is therefore catalytically self-sufficient (Narhi & Fulco, 1986) . The gene encoding P-450 BM-3 has been cloned and sequenced (CYP102; Wen & Fulco, 1987; Ruettinger et al., 1989) , and detailed comparisons of the predicted amino acid sequence have shown that the P-450 domain is most closely related to mammalian fatty acid-metabolizing P-450s of family 4 (25 % identity) rather than any other bacterial P-450s (Nebert et al., 1991) . Similarly, the reductase domain is approx. 33 % identical with P-450 reductases from several eukaryotic sources, including man, and contains all of the conserved residues associated with binding of the FAD and FMN cofactors, and NADPH (Ruettinger et al., 1989) . Clearly, this unique configuration suggests that P-450 BM-3 is a very attractive model for understanding many aspects of P-450 function, not least because it is soluble, unlike almnost all eukaryotic P-450s, and it can be expressed to a very high level in Escherichia coli (Narhi et al., 1988; Boddupalli et al., 1990) .
A further intriguing aspect of P-450 BM-3 is that it gives rise to two distinct hydroxylated products with lauric acid and myristic acid as substrate, but also catalyses multiple rounds of oxidation of palmitic acid, where the products of one round are the substrates for the next and the fatty acid/02 ratio is 3: 1 when palmitic acid is present at high concentration (Boddupalli et al., 1990 (Boddupalli et al., , 1992 .
The two domains of P-450 BM-3 can be separated by treatment with trypsin. However, in the absence of substrate the N-terminus of the P-450 domain is also cleaved at positions 9 and 15, thus losing its ability to bind substrate (Narhi & Fulco, 1987) . Although the N-terminus of the reductase domain has been defined by protein sequencing, the C-terminus of the P-450 domain has not been determined, and from the sequence there are several potential tryptic cleavage sites in the interdomain region which could lead to heterogeneity of this domain (Ruettinger et al., 1989) . Similarly, the reductase domain generated by trypsin treatment appears to be heterogeneous when eluted from anion-exchange h.p.l.c. (Narhi & Fulco, 1987) .
In order to begin investigations of the properties of the two domains, and in particular to compare the P-450 domain with the well-characterized soluble bacterial P-450 cam (Martinis et al., 1991) , with which it shares only 15 % sequence identity, we decided to make genetic constructs which can overexpress both the P-450 and reductase domains independently of each other in E. coli. This paper describes the construction and expression of Vol. 288 503 Abbreviations used: PMSF, phenylmethanesulphonyl fluoride; P-450, cytochrome P-450-dependent mixed-function mono-oxygenase.
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subgenes encoding such domains, purification of the domains, characterization of the P-450 domain and holoenzyme using e.p.r. and resonance Raman spectroscopy, and reconstitution of mono-oxygenase activity by mixing the two individual domains.
During the preparation of this paper, reports of the generation of the two domains of P-450 BM-3 and their characterization by u.v.-visible spectroscopy were published (Li et al., 1991; Oster et al., 1991) . The work described here extends the characterization of this unique system, with studies using additional spectroscopic techniques. The widespread interest in P-450 BM-3 reflects its potential use as a model system for studying domain interactions and intramolecular electron-transfer processes in P-450 systems. (Vieira & Messing, 1987) and XL-1 Blue (supE44 hsdR17 recA 1 endA 1 gyrA46 thi relAl lac-F' [proABi lacP lacZAM15 TnJO(tetr)]) (Bullock et al., 1987) . The following vectors were used: bacteriophage M 13mpl 8 (Yanisch-Perron et al., 1985) for DNA sequencing; and plasmids pUC1 18 (Vieira & Messing, 1987) and ptac85 (Marsh, 1986) for overexpression.
EXPERIMENTAL

PCR and DNA sequencing
The PCRs (Saiki et al., 1988) were performed as follows. Targets were either B. megaterium ATCC 14581 genomic DNA (100 ng) or plasmid DNA (1 ng); 1 lsg of each of the relevant pairs of oligonucleotides and 200 ,tM-dNTPs were added to a reaction volume of 100 lld. Taq DNA polymerase (2.5 units per reaction) and reaction buffer were from Promega (Chilworth Research Centre, Southampton, U.K.). Twenty-five cycles of 1 min, 94°C, 2 min, 55°C and 3 min, 72°C for the genomic DNA target, and 15 cycles for the plasmid DNA target were carried out in a Perkin-Elmer Cetus Thermal Cycler.
Oligonucleotide sequences were: P9, hybridizing to positions 1525-1548 in the CYP102 gene sequence (Reuttinger et al., 1989) , adding an EcoRI site upstream of the ribosome-binding site and PlO, hybridizing to positions 2963-2933, which introduces tandem stop codons at the end of the P-450-domaincoding region (position 2957) and also a BamHI site; P1, hybridizing to positions 4822-4800 downstream ofthe terminator of the CYP102 gene adding a BamHI site; and P24, hybridizing to positions 2957-2973 at the start of the reductase-domaincoding region adding a BamHI site. PCR products were subcloned into M13mpl 8 and fully sequenced using the dideoxy chain-termination method (Sanger et al., 1980 ) and a series of specific sequencing primers to confirm their structure.
Other molecular-biology methods DNA manipulations, bacterial transformations and other molecular-biology methods were by standard methods (Sambrook et al., 1989) .
Purification of the P450 domain
All purification steps were done at 4°C unless stated otherwise. XL-1 Blue (pJM20) was the source of the P-450 domain, and 20-25 g of wet cells was the starting point for purification. The P-450 domain was purified in a similar manner to that described by Li et al. (1991) except that the initial ion-exchange chromatography step was performed using DEAE-Sephacel. After DEAE-Sephacel chromatography, fractions with an absorbance ratio A419/A280 > 0.5 were retained and applied to Bio-Gel HTP (DNA grade) hydroxyapatite (12 cm x 3 cm column). The protein was eluted with a linear gradient of 25-450 mM-potassium phosphate, pH 6.5. Fractions containing material with A419/A280 > 1.2 were pooled and applied to an f.p.l.c. Mono Q column. The protein was eluted in a linear gradient of 0-250 mM-KCl in buffer A (50 mM-Tris/HCl, pH 8.0, 1 mM-EDTA, 2 mM-2-mercaptoethanol), and pooled fractions with A419/A280> 1.6 were retained for further study.
Purification of reductase domain XL-1 Blue (pJM27) was the source of the reductase domain. A crude extract was prepared and protein precipitating between 30 % and 60 % saturation with (NH4)2SO4 contained the bulk of the reductase domain. The precipitated protein was resuspended in buffer A containing 1 mM-benzamidine plus 60,ug of phenylmethanesulphonyl fluoride (PMSF)/ml, dialysed and applied to the DEAE-Sephacel column. The column was washed, and the protein eluted with a linear gradient of 0-500 mM-KCl in buffer A (300 ml). The most intensely yellow fractions, containing P-450 reductase and eluted at about 130 mM-KCl, were pooled and dialysed against 2 x 11 litre of buffer B (10 mM-potassium phosphate, 0.02 mM-EDTA, pH 7.7, 0.2 mM-2-mercaptoethanol, 60 ,ug of PMSF/ml, 1 mM-benzamidine). The reductase domain was purified to homogeneity in a further step using 2'5'-ADP-Sepharose affinity chromatography, essentially as described by Li et al. (1991) .
Purification of cytochrome P450 BM-3 XL-1 Blue (pJM23) was the source of intact P-450 BM-3. Cytochrome P-450 BM-3 was purified in a similar manner to that described by Boddupalli et al. (1990) , except that the final step involved 2'5'-ADP-Sepharose affinity chromatography, essentially as described by Li et al. (1991) , rather than gel filtration.
Spectroscopy and enzyme assays
All u.v.-visible spectroscopy was performed on a Shimadzu 2100 spectrophotometer. Protein concentration was determined by the method of Lowry et al. (1951) with BSA as standard. Cytochrome P-450 concentrations were measured by the method of Omura & Sato (1964) using c = 91 mm-'Icm-l for the reduced plus CO adduct at 450 nm. Cytochrome c reductase activity was measured at 30°C by following the NADPH-dependent increase in absorbance at 550 nm, e = 21 mm-1 cm-'. The assay mixture contained 0.3 M-potassium phosphate, pH 8.0, 1.5 mg of cytochrome c/ml and 0.2 mM-NADPH. Fatty acid hydroxylation was measured using a spectrophotometric assay (Matson et al., 1977) . The assay mixture contained 0.5 mM-sodium laurate and 0.2 mM-NADPH in 0.1 M-potassium phosphate, pH 8.0, and the decrease in absorbance at 340 nm was followed, using e = 6.2 mm-' cm-' at 30 'C. Concentration of the cytochrome P-450 reductase domain was estimated using e = 21.2 mm--, -cm-' at 456 nm (Vermilion & Coon, 1978 
RESULTS AND DISCUSSION
Genes and subgenes expressing domains of P450 The CYP102 gene expressing intact P-450 BM-3 and subgenes expressing either the P-450 domain or the reductase domain were constructed as described in the Experimental section. Genomic DNA from B. megaterium ATCC 14581 was isolated, a 1.5 kb fragment amplified using PCR primers P9 and PlO, its sequence confirmed, and the fragment transferred into pUCi 18 to give pJM20. This construct contains a subgene expressing the first 472 amino acids of P-450 BM-3 constituting the P-450 domain and is expressed from the lac promoter in pJM20.
The entire CYP102 gene was known to reside on a 5 kb BglII fragment (Wen & Fulco, 1987) . We cloned this fragment, from genomic DNA, into pUCi 19 to give pJM23. As expected, pJM23 expresses intact P-450 BM-3 from its own promoter. Amplification of pJM23 DNA using PCR primers P24 and P1 generates a 1.8 kb subgene which encodes residues 473-1049 of P-450 BM-3 and constitutes the reductase domain. The sequence of this fragment was confirmed, and it was cloned into the BamHI site of ptac85 to give pJM27. Primer P24 introduces an ATG initiation codon at positions 2954-2956 immediately preceding the start of the reductase-domain-coding region Purification and characterization of cytochrome P450 BM-3 and its domains
The P-450 domain was purified and the specific content of P-450 haem determined to be 14.2 nmol/mg of protein; this is somewhat lower than the theoretical value of 18.6 nmol/mg based on the molecular mass. However, we believe that the purified P-450 domain is all holoprotein, as analysis by SDS/PAGE, native PAGE and isoelectrofocusing PAGE (pl 4.9) reveals only a single species (Fig. 1) . This was substantiated by its ability to form small (20,um diameter) needle-shaped crystals in its native form from a hanging drop over 200 mM-Tris/HCl, pH 7.62, buffer saturated with 500% (NH4)2SO4; the crystals were too small to mount for X-ray diffraction studies (not shown).
Titration of the P-450 domain with substrate causes a typical Type I shift from 419 nm (low spin) to 397 nm (high spin), giving a spectral K5 for sodium palmitate of approx. I ,CM (not shown); this is similar to the Km of P-450 BM-3 reported for palmitate of approx. 2 /M by Narhi & Fulco (1986) .
The reductase domain was purified to homogeneity and it appears to be a single species as judged by SDS/PAGE (Fig. 1 aL (1991) . The cytochrome c reductase activity of the reductase domain is 2900 nmol/min per nmol. The intact cytochrome P-450 BM-3 was purified (Fig. 1) . The specific content of P-450 haem is 5.6 nmol/mg compared with a theoretical value of 8.4 nmol/mg; others have reported a similar discrepancy (Boddupalli et al., 1990) . The fatty acid (sodium laurate) hydroxylation activity was measured as 890 nmol/min per nmol and the cytochrome c reductase activity was 3500 nmol/min per nmol, slightly higher than the activity of the individual reductase domain. The assay mixtures contained 89 nM-P450 BM-3.
The u.v.-visible spectra of the oxidized, dithionite-reduced, and reduced plus CO forms of the haemoproteins, and the oxidized and dithionite-reduced reductase domain are essentially as reported previously (Narhi & Fulco, 1986; Li et al., 1991; Oster et al., 1991) .
Reconstitution of fatty acid hydroxylase activity by mixing domains Attempts were made to reconstitute the fatty acid hydroxylation activity associated with the intact P-450 BM-3 by mixing together the individual domains. Under conditions comparable with assaying P-450 BM-3, mixtures containing 89 nm each of P-450 and reductase domains when assayed failed to show any activity. Increasing the reductase domain concentration fivefold to 450 nm did not. give activity. However, assay mixtures containing the P-450 domain at 720 nm and the reductase domain at 3600 nM gave an activity of 1.0 nmol/min per nmol of P-450 domain, i.e. about one thousandth of the specific activity of P-450 BM-3, but comparable with the specific activities found for reconstituted mammalian P-450s (e.g. see Wolf et al., 1988; Guengerich, 1991) . This is in contrast with previous attempts by others to reconstitute activity using individual domains produced by genetic engineering (Li et al., 1991) or by limited trypsinolysis of intact P-450 BM-3 (Narhi & Fulco 1987) . Our results suggest that the very high specific activity of P-450 BM-3 is due to the physical linkage of the P-450 domain to the reductase domain. The interdomain linkage may not play a passive role, but rather it may be vital for domain orientation and interaction to promote high catalytic activity. E.p.r. spectroscopy of the haem group of P450 domain and holoprotein
The X-band e.p.r. spectra of the oxidized form of the P-450 haem domain and of the holoprotein recorded at 10 K are shown in Fig. 2 . The only signals are from the low-spin ferric haem at g 2.42, 2.26 and 1.92 in the haem domain and g 2.41, 2.25, 1.92 in the holoprotein. These g-values are well within the ranges reported for other P-450s (2.39-2.46, 2.23-2.30 and 1.90-1.93; Chevion et al., 1977) . Indeed, the spectra are virtually identical with those of the low-spin ferric form of P-450 cam (g 2.45, 2.26, 1.91; Dawson et al., 1982; Lipscomb, 1980) . The g-values are sensitive to the nature of the haem axial ligands and to perturbations such as the orientations of the ligands. These results show that the haem ligation in P-450 BM-3 is identical with that of P-450 cam. The presence or absence of the flavin domain does not affect the haem state in the oxidized resting state.
Since the P-450 domain of P-450 BM-3 is expressed to a high level in E. coli cells, the e.p.r. spectrum of the whole cells has been recorded (Fig. 3) . The spectrum of the low-spin ferric P-450 is clearly detected. The level is sufficiently high that no other e.p.r. The resonance Raman spectra of the substrate-bound and substrate-free P-450 domains have been recorded (Fig. 4) . The substrate-free P-450 haem iron exists in the ferric (Fe3+) 450 cam about the periphery of the haem group which will arise as a result of the low sequence similarity (15 % identity).
Assignment of the band at 350 cm-' may be made to Fe-SCYS.
Additional low-frequency features are observed between 400 and 500 cm-' and the band at 428 cm-' may be attributable to Fe-°a xial stretching. The bands at 678 cm-' and 756 cm-' are assigned to 7 and vPi respectively. The latter mode has been proposed to be the Jahn-Teller active vibration for metalloporphyrins and metallophthalocyanines (Bovill et al., 1992) . Addition of palmitate (1 mm final concentration) to the P-450 domain produced the high-frequency spectrum shown in Fig.  3(b) and reveals a substrate-induced protein haem low-to-high spin state change. This is indicated by the broad bands attributable to v2 and v,o at 1575 cm-' and 1625 cm-' respectively. These lower frequencies, as compared with those observed with the substrate-free protein, can be correlated with five-coordinate high-spin-state haem.
Conclusions
The high-level expression of P-450 BM-3 and its two functional domains in E. coli, and their relatively facile purification, allows large quantities of protein to be produced for biophysical and biochemical studies. The similarity of the P-450 domain to members of P-450 family 4, and the reductase domain to eukaryotic P-450 reductases, means that the holoprotein and the individual domains provide excellent models for the microsomal P-450 system. In particular, P-450 BM-3 can now be used as an alternative model to that of P-450 cam. The e.p.r. studies described in this work indicate that the haem ligation of the P-450 domain, and P-450 BM-3, is identical with P-450 cam.
Interestingly, the presence of the reductase domain in the intact P-450 BM-3 does not modify the e.p.r. spectrum, indicating that interaction of the two domains does not change the haem ligation state. Further studies of the haem environment and ligation state of the P-450 domain and P-450 BM-3 will be made using near-i.r. magnetic c.d. spectroscopy.
Comparison of the resonance Raman spectrum of the substrate-free P-450 domain with the equivalent spectrum of P-450 cam suggests that the peripheral interactions of the protein with the protoporphyrin IX, especially the vinyl groups, is somewhat different from that in P-450 cam. Although the amino acid sequence similarity between the P-450 domain and P-450 cam is highest around the conserved cysteine ligand to the haem iron, there is still considerable variation in residues which may contact the haem and which may cause subtle alterations of the haem electronic structure. Further studies of the P-450 domain and intact P-450 BM-3, including a comparison of the resonance Raman and surface-enhanced resonance Raman spectra [Rospendowski et al. (1991) and references therein], will help clarify this point. Fluorescence interference obscures the resonance Raman spectra of the intact P-450 BM-3 under the existing experimental conditions, but low-temperature studies may help.
The observations that the catalytic rate of a mixture of the two individual domains is comparable with those found for reconstituted mammalian microsomal P-450s suggests that the covalent linkage of the two domains is the key to the high catalytic rate in the intact P-450 BM-3. Future work in this direction should be aimed at making fusion proteins containing either the P-450 domain of P-450 BM-3 and eukaryotic The resonance Raman spectra of (a) the low-spin ferric substrate-free P-450 domain and (b) the high-spin ferric substrate-bound P-450 domain. A 428.1 nm laser line (10 mW nominal power) was used to excite the haemoprotein. The protein samples were (a) 170 /M P-450 domain in buffer A including 50 % (v/v) glycerol and (b) an equal volume of this mixed with palmitate dissolved in 50 mM-potassium carbonate, pH 8.0, to give a final concentration of substrate of about 1 mm. The salient features of the spectra are described in the Results and Discussion section. The deterioration of the signal-to-noise ratio for the substrate-bound versus substrate-free spectrum can be rationalized on the basis of the hypsochromic shift in the Soret band Amax = 419-397 nm on addition of substrate. The 428.1 nm laser excitation line is further off-resonance with respect to the high-spin-state haem electronic Soret transition. In the overtone and combination band region (1700-3500 cm-1), only barely detectable features were observed (not shown). The peaks due to glycerol are marked.
reductases, or mammalian microsomal P-450s with the reductase domain of P-450 BM-3 to determine whether such proteins can be expressed in E. coli and an increase in catalytic activity can be achieved.
